Literature DB >> 6419482

Immunogenicity of xenogeneic cartilage matrix components in a rabbit model.

G E Friedlaender, I M Ladenbauer-Bellis, O D Chrisman.   

Abstract

Purified xenogeneic cartilage matrix components, including proteoglycan subunits, chondroitin 4 sulfate, and chondroitin 6 sulfate, were inoculated into the knee joint of rabbits, and local as well as systemic responses were evaluated. proteoglycan was associated with synovial hyperplasia and infiltrates of eosinophils and lymphocytes and with rising titers of antiproteoglycan antibodies in a tanned sheep rbc hemagglutination assay over a six-week period of weekly intra-articular injections and observations. Chondroitin sulfates failed to evoke detectable changes in the joint or serum. Immunogenicity of cartilage matrix components may play a role in allogeneic and xenogeneic osteochondral grafts, and it is also possible that autogenous matrix immunogens exist and contribute to progression of degenerative joint disease. The immunogenicity of allogeneic and autogenous cartilage matrix components remains undefined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6419482      PMCID: PMC2589671     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  23 in total

1.  Biochemical aspects of degenerative joint disease.

Authors:  O D Chrisman
Journal:  Clin Orthop Relat Res       Date:  1969 May-Jun       Impact factor: 4.176

2.  The permeability of articular cartilage.

Authors:  A Maroudas; P Bullough; S A Swanson; M A Freeman
Journal:  J Bone Joint Surg Br       Date:  1968-02

3.  The role of cartilage polysaccharides in osteoarthritis.

Authors:  R C George; O D Chrisman
Journal:  Clin Orthop Relat Res       Date:  1968 Mar-Apr       Impact factor: 4.176

Review 4.  The response of articular cartilage to mechanical injury.

Authors:  H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1982-03       Impact factor: 5.284

5.  Matrix antigens in allografts. The humoral response.

Authors:  I G Yablon; S Cooperband; D Covall
Journal:  Clin Orthop Relat Res       Date:  1982-08       Impact factor: 4.176

6.  Isolation and characterization of proteoglycans from human chondrosarcomas.

Authors:  S Pal; W Strider; R Margolis; G Gallo; S Lee-Huang
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

7.  The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors.

Authors:  H J Mankin; K P Cantley; A L Schiller; L Lippiello
Journal:  J Bone Joint Surg Am       Date:  1980-03       Impact factor: 5.284

8.  Salicylate inhibition of cartilage degeneration.

Authors:  D P Simmons; O D Chrisman
Journal:  Arthritis Rheum       Date:  1965-10

9.  EXPERIMENTAL PRODUCTION OF SYNOVITIS AND MARGINAL ARTICULAR EXOSTOSES IN THE KNEE JOINTS OF DOGS.

Authors:  O D CHRISMAN; J M FESSEL; W O SOUTHWICK
Journal:  Yale J Biol Med       Date:  1965-04

10.  Immunochemical analysis of cartilage proteoglycans. Antigenic determinants of substructures.

Authors:  J Wieslander; D Heinegård
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

View more
  5 in total

1.  Effects of antigen removal on a porcine osteochondral xenograft for articular cartilage repair.

Authors:  Steve Elder; Hudson Chenault; Paul Gloth; Katie Webb; Ruth Recinos; Emily Wright; Dalton Moran; James Butler; Abdolsamad Borazjani; Avery Cooley
Journal:  J Biomed Mater Res A       Date:  2018-05-25       Impact factor: 4.396

2.  Fine specificity of serum anticollagen molecules in experimental immune synovitis.

Authors:  T F Kresina; I A Rosner; V M Goldberg; R W Moskowitz
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

3.  Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis.

Authors:  J U Yoo; T F Kresina; C J Malemud; V M Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Cartilage immunoprivilege depends on donor source and lesion location.

Authors:  B Arzi; G D DuRaine; C A Lee; D J Huey; D L Borjesson; B G Murphy; J C Y Hu; N Baumgarth; K A Athanasiou
Journal:  Acta Biomater       Date:  2015-05-28       Impact factor: 8.947

5.  Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values.

Authors:  Afaf El-Ansary; Manan Alhakbany; Abeer Aldbass; Hanan Qasem; Sarah Al-Mazidi; Ramesa Shafi Bhat; Laila Al-Ayadhi
Journal:  Lipids Health Dis       Date:  2021-11-06       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.